OTCMKTS:CURR

Cure Pharmaceutical Holding Stock Insider Trading

etoro logo Buy CURR
*Your capital is at risk
$3.11
-0.170 (-5.18%)
At Close: Jun 03, 2026

CURE Pharmaceutical Holding Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 14.96M and sold 0 CURR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 14.96M shares
Sell 0 shares
100% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Salkind Gene Z
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Bell John K
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Held Joshua
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Chung Lauren
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
King-shaw Ruben Jr
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Yuan William
Insider
Other 61 654
Value: $0
Aug 20, 2020
Buy
Common Stock
A-Award
Bell John K
Director
Director 17 601
Value: $0
Aug 20, 2020
Buy
Common Stock
A-Award
Bell John K
Director
Director 17 601
Value: $0
Aug 19, 2020
Buy
Common Stock
A-Award
Salkind Gene Z
Director
Director 100 000
Value: $0
Aug 19, 2020
Buy
Common Stock
A-Award
Salkind Gene Z
Director
Director 50 000
Value: $0
Aug 19, 2020
Buy
Common Stock
A-Award
Salkind Gene Z
Director
Director 100 000
Value: $0
Aug 06, 2020
Buy
Common Stock
A-Award
Goldin Anna
Director
Director 21 579
Value: $0
Aug 06, 2020
Buy
Common Stock
A-Award
Chung Lauren
Director
Director 21 579
Value: $0
Jun 05, 2020
Buy
Common Stock
A-Award
Held Joshua
Director
Director 2 106 315
Value: $0
Aug 06, 2019
Buy
Common Stock
J-Other
Chung Lauren
Insider
Other 0
Value: $0
Aug 06, 2019
Buy
Common Stock
J-Other
Goldin Anna
Insider
Other 0
Value: $0
May 13, 2019
Buy
Common Stock
Held Joshua
Director
Director 0
Value: $0
May 13, 2019
Buy
Stock Option
A-Award
Held Joshua
Director
Director 100 000
Value: $401.0K
Feb 15, 2019
Buy
Common Stock
A-Award
Salkind Gene Z
Director
Director 1 621 877
Value: $0
Jan 29, 2019
Buy
Stock Option
A-Award
King-shaw Ruben Jr
Director
Director 100 000
Value: $340.0K
Jan 01, 2019
Buy
Stock Option
A-Award
Salkind Gene Z
Director
Director 100 000
Value: $340.0K
Jan 01, 2019
Buy
Common Stock
A-Award
Salkind Gene Z
Director
Director 250 000
Value: $0
Jan 01, 2019
Buy
Stock Option
A-Award
Yuan William
Insider
Other 100 000
Value: $340.0K
Jan 01, 2018
Buy
Stock Option
A-Award
Udell Mark
Chief Accounting Officer
Officer 150 000
Value: $111.0K
Nov 07, 2016
Buy
Stock Option
A-Award
Yuan William
Insider
Other 100 000
Value: $74.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CURE PHARMACEUTICAL HOLDING CORP.
CURE Pharmaceutical Holding
CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid produc...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE